[1]
“FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS: Outcomes of ASCT in NDMM elderly fit patients”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024066, Aug. 2024, doi: 10.4084/MJHID.2024.066.